<DOC>
	<DOCNO>NCT01352689</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic characteristic CKD-828 ( Fixed Dose Combination Tablet ; Telmisartan S-Amlodipine ) healthy volunteer .</brief_summary>
	<brief_title>CKD-828 ( 80/2.5mg ) Pharmacokinetic Study_2nd</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>A healthy volunteer 20 55 year old body weight within 20 % ideal body weight . Have congenital chronic disease medical symptom . Appropriate study judge examination ( interview , vital sign , 12lead ECG , physical examination , blood , urinalysis result screen ) . Able participate entire trial . Signed informed consent form prior study participation . Take metabolic enzyme induce inhibit drug like barbiturate within 28 day prior first IP administraion . Take oriental medicine inside St John 's Wort metabolism CYP3A4 enzyme inhibite CYP enzyme increase make drug ( itraconazole , ketoconazole , erythromycine , clarithromycine , telithromycin , HIV protease inhibitor ) Disease ( ex : imflammatory intestinal disease , gastric duodenal ulcer , hepatic diseasehistory , gastro intestinal surgery exept appendectomy ) may influence absorption , distribution , metabolism excretion drug ( ) . Relevant hypersensitivity drug clinically significant allergic disease except mild rhinitis n't need medication . Hypersensitivity Telmisartan Amlodipine . SBP &lt; 90mmHg , 150mmHg &lt; SBP DBP &lt; 50mmHg , 100mmHg &lt; DBP . Abnormal laboratory result ( ) : AST ALT &gt; 1.25 time upper limit / Total bilirubin &gt; 1.5 time upper limit . Creatinine Clearance &lt; 80mL/min Clinically significant cardiovascular system , pulmonary system , liver system , renal system , blood system , nervous system hyperpotassemia ( Past history present ) History drug abuse ( sleep tablet , nucleus action painkiller , opiate psychotrope etc central nervous system drug ) show positive urine screening exam . abnormal diet might significantly alter absorption , distribution , metabolism , excretion investigational product ( ex . drinking grapefruit juice ( 1L per day ) 7 week prior first IP administration . ) A heavy caffeine consumer ( 5 cup per day ) heavy smoker ( 10 cigarette per day ) regular alcohol consumer ( 30g/day ) drinking within 7days prior first IP administration . Previously donate whole blood within 60 day component blood within 30 day prior first IP administraion . Medication within 7 day first IP administraion professional medical , medicine , OTC take Participated clinical trial within 60days prior first IP administraion . An impossible one participate clinical trial investigator 's decision</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>CKD-828</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Primary Hypertension</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>S-Amlodipine</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Amlodipine</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Phase 1</keyword>
</DOC>